Medpace Holdings (MEDP) Non-Current Deffered Revenue (2017 - 2018)
Medpace Holdings' (MEDP) quarterly Non-Current Deffered Revenue came in at $4.0 million in Q3 2018, down 81.14% YoY from $21.0 million in Q3 2017, and down 64.26% on a QoQ basis from $11.1 million in Q2 2018.
Medpace Holdings (MEDP) Non-Current Deffered Revenue (2017 - 2018) Analysis & Trends
Medpace Holdings (MEDP) has 2 years of Non-Current Deffered Revenue data on file, last reported at $4.0 million in Q3 2018.
- Quarterly Non-Current Deffered Revenue fell 81.14% year-over-year to $4.0 million in Q3 2018, while the trailing twelve-month figure through Sep 2018 was $4.0 million (down 81.14% YoY) and the FY2017 annual result came in at $11.5 million, changed N/A from the prior year.
- Non-Current Deffered Revenue slipped to $4.0 million in Q3 2018, from $11.1 million in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $21.4 million in Q2 2017 to a low of $4.0 million in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | - |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | - |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 32.59 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | - |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 17.00 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | - |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | - |
| 10 | Medpace Holdings | 16.54 Bn | 16.03 Bn | 201.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 3.95 Mn |
| Jun 30, 2018 | 11.06 Mn |
| Mar 31, 2018 | 11.27 Mn |
| Dec 31, 2017 | 11.47 Mn |
| Sep 30, 2017 | 20.96 Mn |
| Jun 30, 2017 | 21.42 Mn |